Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a ro
EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): ConferenceSecarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs 25.10.2023 / 15:00 CET/CESTThe issuer is solely responsible for the content of t...
Source: pharmiweb.com